Kuwait Oil has tapped SLB for a seven-year partnership aimed at accelerating the deployment of digital and industrial technologies across its upstream operations. The agreement aligns with Kuwait’s national energy objectives, tasking the global services provider with scaling innovation from the laboratory to the oilfield.
A court-supervised bankruptcy process has paved the way for Motorcar Parts of America to acquire a suite of brake-related brands from First Brands Group. The deal secures intellectual and digital property rights for several key aftermarket labels, effectively deepening the company’s footprint in the professional installer and performance vehicle segments.
Ender Ozgun will take the helm at D-Market Electronic Services, the parent company of Hepsiburada, replacing outgoing chief executive Nilhan Gokcetekin. The transition marks a strategic pivot for the Turkish e-commerce giant as it looks to sharpen its focus on core retail operations and logistics network efficiency.
Nearly two years after taking the helm as chief executive, John Shannon will add the role of board chairman to his responsibilities at Xeris Biopharma starting July 1. He succeeds Marla Persky, who transitions to the position of lead independent director while remaining on the board.
A 46% premarket drop hit Unicycive Therapeutics on Tuesday after the FDA issued a second rejection for its lead drug candidate, oxylanthanum carbonate. The agency declined to approve the treatment for dialysis patients, citing unresolved manufacturing deficiencies at an external facility that previously halted the application.
Shares of Aevex climbed 12% to $20.16 in premarket trading Tuesday after the U.S. Air Force awarded the drone manufacturer a $50 million contract. The deal, which includes an immediate $27 million infusion, tasks the company with developing a long-range, precision strike platform designed for high-stakes, contested environments.
A 15.5% intraday plunge for Teleperformance shares followed a bleak revenue forecast from U.S. rival Concentrix, fueling investor anxiety that artificial intelligence is rapidly rendering human-led customer service outsourcing obsolete as clients slash budgets and reevaluate their reliance on third-party support.
Shares of Genmab jumped 6% Tuesday after the Danish biotechnology firm reported that a late-stage trial for its lymphoma therapy successfully met its primary endpoint. The result offers a potential breakthrough in blood cancer treatment, positioning the company to challenge established therapies with a chemotherapy-free regimen.
Oravel Stays, the hospitality technology powerhouse behind the OYO brand, is set to tap India’s equity markets with a $702.7 million initial public offering. The move signals a major shift for the SoftBank-backed firm as it looks to solidify its footprint while navigating a competitive landscape of new-age listings.
A rush of Western importers securing goods from East Asia ahead of impending U.S. tariffs has pushed A.P. Moller-Maersk to sharply upgrade its full-year earnings forecasts. The Danish shipping giant saw its shares climb 5.4% early Monday as the company signaled that sustained market pressure is finally hitting its bottom line.
European indices pushed higher in morning trading as the Stoxx Europe 600 climbed 0.5%, buoyed by gains in Genmab and Siemens Energy. Across the Atlantic, U.S. equity futures remained muted, with S&P 500 contracts edging up 0.1% while Dow Jones Industrial Average futures held steady ahead of the opening bell.
Logly Inc. narrowed its net loss to 73 million yen for the fiscal year ended March 31, 2026, a significant improvement from the 189 million yen loss recorded the previous year. Despite the reduced deficit, the company saw its total revenue contract to 1.42 billion yen from 1.61 billion yen.
Singapore households face rising utility bills this quarter as global natural gas prices surge, a direct consequence of shipping disruptions and ongoing volatility in the Middle East. With 95% of the city-state’s electricity dependent on imported fuel, the Energy Market Authority warns that the cost of living is set to tighten.
Adastria Co. Ltd. reported a net profit of 3.91 billion yen for the first quarter ended May 31, falling short of the 4.37 billion yen recorded during the same period last year. The decline in bottom-line earnings occurred even as the Japanese retailer saw its total revenue climb to 80.32 billion yen.
Techno Alpha Co. Ltd. reported a net profit of 55 million yen for the half-year ending May 31, 2026, marking a decline from the 66 million yen recorded during the same period last year. Despite a boost in overall revenue, the company faced mounting pressure on its bottom line.
Star Mica Holdings reported a significant jump in profitability for the half-year ending May 31, with net profit climbing to 4.36 billion yen from 2.43 billion yen during the same period last year. The results, calculated under Japanese accounting standards, reflect a robust expansion across the firm's financial metrics.
Kuraudia Holdings Co. Ltd. reported a significant uptick in profitability for the nine-month period ending May 31, with net profit climbing to 928 million yen from 634 million yen during the same interval last year, marking a robust expansion in the company's bottom line.
TotalEnergies SE executed a significant share buyback program between June 22 and June 26, 2026, acquiring 1,907,460 shares. The energy giant completed these transactions across the XPAR and CEUX markets, representing a total capital outlay of approximately 133.14 million euros for the five-day period.
A 3.81 billion yen net loss marked a sharp reversal for Daiichi Commodities in the fiscal year ending March 31, 2026, pivoting away from the 236 million yen profit reported the previous year. The Tokyo-based firm struggled under mounting deficits as revenues slipped marginally against the backdrop of Japanese accounting standards.
With a target of US$3.1 billion, Apple assembler Luxshare Precision Industry is preparing for Hong Kong’s largest initial public offering of the year. The move signals a broader shift as Chinese technology firms increasingly turn to the city’s offshore capital markets to fuel their expansion and research capabilities.
China’s manufacturing sector tipped back into expansion this month as robust global demand for artificial intelligence components and green technology offset domestic headwinds. The official purchasing managers index climbed to 50.3 in June, narrowly exceeding economist forecasts and signaling a fragile recovery for the world’s second-largest economy.
Industrial production in Japan climbed by a modest 0.5% in May, failing to meet the 1.1% growth projected by economists. While the figure matches the pace set in April, persistent instability in the Middle East and lingering energy supply anxieties continue to weigh heavily on the nation's manufacturing sector.
Montreal-based BMO Financial Group has moved to bolster its international footprint by acquiring the Australian capital-markets division of Euroz Hartleys Group. The deal, which remains subject to shareholder approval, marks a significant push to capture mining and metals financing activity in a market that mirrors Canada’s own industrial profile.
A 23% drop in after-hours trading greeted Concentrix investors Monday, as the customer-experience firm slashed its full-year outlook. The company now expects adjusted earnings between $10.83 and $11.18 per share, missing Wall Street expectations as clients accelerate offshoring and tighten their enterprise budgets under mounting financial pressure.
The Food and Drug Administration has authorized the use of Arcutis Biotherapeutics’ Zoryve plaque psoriasis cream for children as young as two years old. This regulatory green light expands the product’s label from its previous baseline of six years, widening the scope of available dermatological care for younger patients.
A sharp divergence defined Monday’s after-hours trading, as investors reacted to a flurry of earnings reports and regulatory updates. While AeroVironment and Gain Therapeutics saw double-digit gains following positive fiscal and clinical milestones, Concentrix shareholders faced a steep sell-off after the company issued a cautious outlook for the remainder of the year.
The Food and Drug Administration has delayed its decision on relutrigine, an experimental treatment for rare childhood epilepsy, by three months. The regulatory body extended its target date to December 27, 2026, following the submission of supplementary data from the drug developer, Praxis Precision Medicines.
A retreat in the U.S. dollar coupled with a flurry of high-stakes consolidation pushed raw materials producers higher on Tuesday. The market shift reflects a renewed appetite for industrial assets, underscored by a massive $13.5 billion acquisition in the limestone sector that signaled confidence across the building-materials landscape.
A surge in M&A activity and resurgent interest in artificial intelligence infrastructure pushed industrial and transportation stocks higher this week. The market shift follows a major consolidation in the satellite sector and a sharp valuation spike for manufacturers critical to the scaling of high-performance data centers.
Energy shares retreated today even as U.S.-traded crude futures climbed more than 2 percent. This modest recovery arrives at the end of a punishing second quarter, which concludes Tuesday with oil prices still nursing a roughly 30 percent decline despite the brief intraday rally.
